Atai stock forecast.

According to the issued ratings of 1 analysts in the last year, the consensus rating for Arcadia Biosciences stock is Buy based on the current 1 buy rating for RKDA. The average twelve-month price prediction for Arcadia Biosciences is $15.00 with a high price target of $20.00 and a low price target of $10.00. Learn more on RKDA's analyst rating ...

Atai stock forecast. Things To Know About Atai stock forecast.

Historical daily share price chart and data for Atai Life Sciences since 2008 adjusted for splits and dividends. The latest closing stock price for Atai ...Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.November 30, 2023. EPS forecast (this quarter) -$1.25. Annual revenue (last year) $244.7M. Annual profit (last year) -$358.7M. Net profit margin. NL0015000DX5. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany. Show more.

Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Bird Global Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median ...

A high-level overview of Atai Life Sciences N.V. (ATAI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Find the latest AFC Gamma, Inc. (AFCG) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...

Find the latest Atai Life Sciences N.V. (ATAI) stock quote, history, news and other vital information to help you with your stock trading and investing. Even in a speculative industry, I believe the stock is undervalued by these few facts alone. ATAI holds: 450M cash and cash equivalents; 20% equity stake in CMPS (750M mktcp - 150M worth at current prices); and ATAI has a vast ip pipeline that includes 9 lead compounds. Curious as to the community’s thoughts here!Read an investment analysis of ATAI stock here. ... By 2029, it is forecast to be worth $7.2 billion globally, with a compound annual growth rate of 55%. Also, ...WebWeather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...

Find real-time NEE - Nextera Energy Inc stock quotes, company profile, news and forecasts from CNN Business.

Discover historical prices for ATAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Atai Life Sciences N.V. stock was issued.

Find real-time TLRY - Tilray Brands Inc stock quotes, company profile, news and forecasts from CNN Business.ATAI stock is down 44% year-to-date (YTD), despite a 10% increase over the past month. Shares are changing hands at 2.4x book value. Wall Street’s 12-month median price forecast for ATAI stock ...Find the latest ATAI Life Sciences N.V. ATAI analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating. Shares of the Peter Thiel -backed psychedelic start-up Atai Life Sciences jumped Friday on their first day of trading on Wall Street. The newly listed Nasdaq stock opened up 40% before pulling ...Atai's stock is hurting, but its pipeline is still packed with promising programs. With its shares down by 60% in the last 12 months and a recent layoff …WebAccording to 4 stock analysts, the average 12-month stock price forecast for ATAI stock stock is $13.5, which predicts an increase of 1,015.70%. The lowest …Web

According to TipRanks, Palomeque has an average return of -14.1% and a 28.57% success rate on recommended stocks. Currently, the analyst consensus on ATAI Life Sciences is a Strong Buy with an average price target of $13.75.See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $4.96 and a one-year low of $1.14. Sep 30, 2023.Atai Life Sciences (ATAI) Stock Forecast & Price Prediction. Estimation of the future price movement of Atai Life Sciences stock, based on various factors such as historical price …WebFind real-time ATAI - ATAI Life Sciences NV stock quotes, company profile, news and forecasts from CNN Business.In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.LPTX Stock 12 Months Forecast. Based on 3 Wall Street analysts offering 12 month price targets for Leap Therapeutics in the last 3 months. The average price target is $10.00 with a high forecast of $12.00 and a low forecast of $7.00. The average price target represents a 249.65% change from the last price of $2.86.5 Top Websites for Stock Forecasts. Swati Goyal. Story Highlights. When investors talk about top websites for stock forecasts, their focus is on finding the best investment research service. Researching stocks is a major cornerstone of successful investing, and here you’ll find websites that can make your work easy. Share.

On July 10, 2023, the stock experienced a significant increase, driven by positive forecasts and a strong consensus among investment analysts. According to data from CNN Money, the 12-month price forecasts for ATAI stock have a median target of 11.00, with a high estimate of 21.00 and a low estimate of 6.00.

The stock ranks in the lowest position of the 53 stocks owned by the ETF. Atai was the third psychedelics company to go public with an IPO in June 2021, following Mind Medicine Inc MNMD and ...About the ATAI Life Sciences N.V. stock forecast. As of 2023 November 11, Saturday current price of ATAI stock is 1.160$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. ATAI Life Sciences N.V. stock price has been showing a declining tendency so we believe that similar market segments …Nov 30, 2023 · According to the issued ratings of 4 analysts in the last year, the consensus rating for Atai Life Sciences stock is Buy based on the current 4 buy ratings for ATAI. The average twelve-month price prediction for Atai Life Sciences is $12.80 with a high price target of $20.00 and a low price target of $9.00. Learn more on ATAI's analyst rating ... A. While ratings are subjective and will change, the latest ATAI Life Sciences ( ATAI) rating was a reiterated with a price target of $0.00 to $20.00. The current price ATAI Life Sciences ( ATAI ...Atari S.A. is an interactive entertainment company and an iconic gaming industry brand that transcends generations and audiences. The company is globally recognized for its multi-platform, interactive entertainment and licensed products.Nov 29, 2023 · Read an investment analysis of ATAI stock here. ... By 2029, it is forecast to be worth $7.2 billion globally, with a compound annual growth rate of 55%. Also, ...

ADMA Stock 12 Months Forecast. $6.00. (51.90% Upside) Based on 2 Wall Street analysts offering 12 month price targets for ADMA Biologics in the last 3 months. The average price target is $6.00 with a high forecast of $7.00 and a low forecast of $5.00. The average price target represents a 51.90% change from the last price of $3.95.

Since Atai Life Sciences is only going public, we don’t have any forecast for the stock. Also, being a clinical-stage company, we don’t have earnings-based metrics to value the stock.

Find latest ATAI Life Sciences N.V. (ATAI) stock discussions and message board on Twitter, StocksTwits, Reddit, SeekingAlpha and other social media. Stock Screener App. Free - Install. Dark EN. Sign in. ... Discussions Forecast. ATAI Life Sciences N.V. (ATAI) Stock Discussion & Message BoardStock Price Forecast The 6 analysts offering 12-month price forecasts for Ouster Inc have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 6.00. According to 4 stock analysts, the average 12-month stock price forecast for ATAI stock stock is $13.5, which predicts an increase of 1,015.70%. The lowest …WebThe company's stock is trading at about 20 cents per share as of Oct. 24. Cybin Inc . ( CYBN) Cybin, a Canadian psychedelic drug developer that produces treatments for depression, anxiety and ...That said, analysts are starting to come around on ATAI. H.C. Wainwright biotech analyst Patrick Trucchio maintained a "buy" rating on Atai in early October, with a price target of $20. Its ...28.98. According to our current ATAI stock forecast, the value of Atai Life Sciences N.V. shares will drop by -18.90% and reach $ 0.875911 per share by December 3, 2023. …WebStock Price Forecast The 5 analysts offering 12-month price forecasts for ATAI Life Sciences NV have a median target of 11.00, with a high estimate of 21.00 and a low estimate of 6.00. The median estimate represents a +873.45% increase from the last price of 1.13. ACIU Stock 12 Months Forecast. Based on 2 Wall Street analysts offering 12 month price targets for AC Immune SA in the last 3 months. The average price target is $16.00 with a high forecast of $16.00 and a low forecast of $16.00. The average price target represents a 417.80% change from the last price of $3.09.With its shares down by 60% in the last 12 months and a recent layoff affecting 30% of its workforce, it's fair to say that Atai Life Sciences ( ATAI 1.87%) is having a rough go of things lately ...When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.4 brokers have issued 1-year price targets for Atai Life Sciences' stock. Their ATAI share price targets range from $9.00 to $20.00. On average, they expect the …Web

According to the issued ratings of 1 analysts in the last year, the consensus rating for Arcadia Biosciences stock is Buy based on the current 1 buy rating for RKDA. The average twelve-month price prediction for Arcadia Biosciences is $15.00 with a high price target of $20.00 and a low price target of $10.00. Learn more on RKDA's analyst …Get the latest Mind Medicine (MindMed) Inc (MNMD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.ATAI Life Sciences NV Stock Forecast. Is ATAI Life Sciences NV Stock Undervalued? The current ATAI Life Sciences NV [ ATAI] share price is $1.06. The Score for ATAI is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. ATAI is currently trading in the 10-20% percentile range relative to its historical ...That said, analysts are starting to come around on ATAI. H.C. Wainwright biotech analyst Patrick Trucchio maintained a "buy" rating on Atai in early October, with a price target of $20. Its ...Instagram:https://instagram. swstxforex broker platformhow to sell stocks on robinhood and cash outwhat year quarters are worth money (NASDAQ: ATAI) Atai Life Sciences Nv stock price per share is $1.17 today (as of Nov 10, 2023).Find real-time CRM - Salesforce Inc stock quotes, company profile, news and forecasts from CNN Business. lenders in texascharting tools Atai Life Sciences has a strong pipeline of drugs for the next 18 months, and will pursue aggressive growth. The company had $335 million in cash as of May 2022, which is roughly 50% of its ...ATAI Life Sciences N.V. analyst ratings, historical stock prices, earnings estimates & actuals. ATAI updated stock price target summary. how to make money off cash app stocks 4 brokers have issued 1-year price targets for Atai Life Sciences' stock. Their ATAI share price targets range from $9.00 to $20.00. On average, they expect the company's stock price to reach $12.80 in the next twelve months. This suggests a possible upside of 1,063.6% from the stock's current price.Find real-time ATAI - ATAI Life Sciences NV stock quotes, company profile, news and forecasts from CNN Business.Web